These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Current understanding of cancer stem cells: Immune evasion and targeted immunotherapy in gastrointestinal malignancies. An J; Hu X; Liu F Front Oncol; 2023; 13():1114621. PubMed ID: 36910604 [TBL] [Abstract][Full Text] [Related]
5. Update on immune-based therapy strategies targeting cancer stem cells. Izadpanah A; Mohammadkhani N; Masoudnia M; Ghasemzad M; Saeedian A; Mehdizadeh H; Poorebrahim M; Ebrahimi M Cancer Med; 2023 Sep; 12(18):18960-18980. PubMed ID: 37698048 [TBL] [Abstract][Full Text] [Related]
6. A New Approach for Cancer Immunotherapy Based on the Cancer Stem Cell Antigens Properties. Mahmoodi S; Nezafat N; Negahdaripour M; Ghasemi Y Curr Mol Med; 2019; 19(1):2-11. PubMed ID: 30714514 [TBL] [Abstract][Full Text] [Related]
7. Natural killer cell-based immunotherapy: From transplantation toward targeting cancer stem cells. Dianat-Moghadam H; Rokni M; Marofi F; Panahi Y; Yousefi M J Cell Physiol; 2018 Jan; 234(1):259-273. PubMed ID: 30144312 [TBL] [Abstract][Full Text] [Related]
8. Crosstalk between colorectal CSCs and immune cells in tumorigenesis, and strategies for targeting colorectal CSCs. Zhao Q; Zong H; Zhu P; Su C; Tang W; Chen Z; Jin S Exp Hematol Oncol; 2024 Jan; 13(1):6. PubMed ID: 38254219 [TBL] [Abstract][Full Text] [Related]
9. NK Cells Preferentially Target Tumor Cells with a Cancer Stem Cell Phenotype. Ames E; Canter RJ; Grossenbacher SK; Mac S; Chen M; Smith RC; Hagino T; Perez-Cunningham J; Sckisel GD; Urayama S; Monjazeb AM; Fragoso RC; Sayers TJ; Murphy WJ J Immunol; 2015 Oct; 195(8):4010-9. PubMed ID: 26363055 [TBL] [Abstract][Full Text] [Related]
10. Immunologic Targeting of Cancer Stem Cells. Zhang J; Li Q; Chang AE Surg Oncol Clin N Am; 2019 Jul; 28(3):431-445. PubMed ID: 31079798 [TBL] [Abstract][Full Text] [Related]
11. Cancer stem cell immunology and immunotherapy: Harnessing the immune system against cancer's source. Ruiu R; Tarone L; Rolih V; Barutello G; Bolli E; Riccardo F; Cavallo F; Conti L Prog Mol Biol Transl Sci; 2019; 164():119-188. PubMed ID: 31383404 [TBL] [Abstract][Full Text] [Related]
12. Therapeutic gene modified cell based cancer vaccines. Kozłowska A; Mackiewicz J; Mackiewicz A Gene; 2013 Aug; 525(2):200-7. PubMed ID: 23566846 [TBL] [Abstract][Full Text] [Related]
13. Natural killer cell therapy targeting cancer stem cells: Old wine in a new bottle. Guo F; Zhang Y; Bai L; Cui J Cancer Lett; 2023 Aug; 570():216328. PubMed ID: 37499742 [TBL] [Abstract][Full Text] [Related]
15. Evolving Strategies for Therapeutically Targeting Cancer Stem Cells. Talukdar S; Emdad L; Das SK; Sarkar D; Fisher PB Adv Cancer Res; 2016; 131():159-91. PubMed ID: 27451127 [TBL] [Abstract][Full Text] [Related]
16. Resistance to Cell Death and Its Modulation in Cancer Stem Cells. Safa AR Crit Rev Oncog; 2016; 21(3-4):203-219. PubMed ID: 27915972 [TBL] [Abstract][Full Text] [Related]
17. Immune response against tumor antigens expressed on human cancer stem-like cells/tumor-initiating cells. Hirohashi Y; Torigoe T; Inoda S; Takahashi A; Morita R; Nishizawa S; Tamura Y; Suzuki H; Toyota M; Sato N Immunotherapy; 2010 Mar; 2(2):201-11. PubMed ID: 20635928 [TBL] [Abstract][Full Text] [Related]
18. The role of aldehyde dehydrogenase (ALDH) in cancer drug resistance. Januchowski R; Wojtowicz K; Zabel M Biomed Pharmacother; 2013 Sep; 67(7):669-80. PubMed ID: 23721823 [TBL] [Abstract][Full Text] [Related]
19. Recent Advances in Cancer Stem Cell-Targeted Immunotherapy. Badrinath N; Yoo SY Cancers (Basel); 2019 Mar; 11(3):. PubMed ID: 30841635 [TBL] [Abstract][Full Text] [Related]
20. Effect of targeted ovarian cancer immunotherapy using ovarian cancer stem cell vaccine. Wu D; Wang J; Cai Y; Ren M; Zhang Y; Shi F; Zhao F; He X; Pan M; Yan C; Dou J J Ovarian Res; 2015 Oct; 8():68. PubMed ID: 26497895 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]